Eps8 is called the key component of the motor that ensures that dendritic cells, a specialised patrolof the immune system, are activated in moments of danger and run to sound the alarm and activatethe body's cellular defence teams. Without this protein dendritic cells, which monitor organs andtissues for viruses, bacteria parasites and also altered cells, including tumour cells, are still able tosense danger signals, but like amputees, they remain almost immobile and cannot effectively reachthe command centres where they should sound the alarm.
The disastrous result of their poor abilityto move is failure to activate the immune response.
The discovery, made by a team of researchers atthe IFOM and the IEO in Milan directed by Giorgio Scita and Maria Rescigno, working in collaborationwith the University of Milan, is published in the latest issue of the scientific journal Immunity.Intercept the enemy, identify it and sound the alarm: this is essentially the role of dendritic cells, one of themost important radar systems that the immune system has at its disposal for developing strong andefficacious defences against possible insults that could compromise health from the outside or from within.
To achieve this they must travel through organs and tissues, to peripheral districts such as the skin or theintestine, where they register the danger signals, to the lymph nodes, veritable immunological commandcentres.What is the motor that drives this machine, whose function is so vital for the body? It has long been knownthat the basic component of the propulsion mechanism on which the migratory capacity of dendriticcells is based is a protein that is fundamental for all types of cellular movement, actin.
Alone, however, it is not sufficient and the study conducted by Giorgio Scita, researcher at IFOM (IstitutoFIRC di Oncologia Molecolare) and Associate Professor of General Pathology in the Department ofMedicine, Surgery and Dentistry at the University of Milan, and by Maria Rescigno, researcher working atthe IEO (Istituto Europeo di Oncologia Molecolare), now identify a new component that is essential for themovement of dendritic cells.
It is the Eps8 protein: its fine tuning of the dynamic behaviour of actin is indispensible for these cells tomove and to travel to trigger the immune response.«Once dendritic cells have identified their target – explains Maria Rescigno, an immunology expert whocoordinates the research program entitled "Immunobiology of dendritic cells and immunotherapy" – theyengulf it and then load some of its highly characteristic molecular features, its so-called antigens, onto theirown surface.
After having practically eaten the enemy – the scientist continues – dendritic cells undertake atortuous journey through organs and tissues. They reach the lymph nodes and present the antigen, in thisway passing the information about the threat to other elements of the immune system. In this way theT- and B-lymphocytes, real patrols specialised in counter-attacking, are instructed to recognise the enemyand activated so that the body can raise its defences against it.
Therefore, movement is fundamental to defence and acquiring the capacity to move through tissuesrepresents a crucial step in dendritic cell maturation."Movement is a key event in many normal and pathological cellular processes, such as those that takeplace during embryonic development or the dissemination of tumour metastases" affirms GiorgioScita, who has studied the molecular phenomena linked to cellular migration for many years and coordinatesthe IFOM research program entitled "Membrane and actin dynamics in the control of migratory and invasivestrategies".
And it is certainly important – continues the Scientist – also in the functioning of the immunesystem. In particular, in performing the tasks assigned to the dendritic cells, which are practically obligatedto move in order to trigger the immune response.
It was known that these cells have an extraordinary capacity to adapt in an extremely flexible manner to thevarious environmental conditions that they encounter during their journey to the lymph nodes.
In fact, alongthe way they pass through microenvironments (defined by the various tissues in the body) that differ greatlyin their chemical and physical characteristics, and degree of rigidity.
It was also known that this flexibility is based on the use of different migration strategies, but thecharacteristics of the motor that drives this machine and that, in the final analysis, permits the immunesystem to better monitor and defend the body, remained unclear.«For this reason we have concentrated our research on cellular elements that can influence the basiccomponents of this motor, actin – explains Scita – and in particular on Eps8, a protein that embraces the endof the chain formed by actin, regulating the functions».
In cells, the blocks of actin assemble and disassemble in an oriented way in a characteristic andfundamental structure, the actin cytoskeleton.
Despite what the name suggests, this structure is anythingbut static and its continuous remodelling generates the force that allows the cell to move: it is becauseof this fact that cellular protrusions can form that, analogous to arms, legs or tentacles, can pushagainst the three-dimensional matrix that serves as the substrate for the cells of the various organs andtissues; they cling to its fibres and permit the cell to drag itself with a motion reminiscent of crawling.
Also the dendritic cells move in this way on their way to the lymph nodes, after having received a dangersignal.
The researchers Emanuela Frittoli at IFOM and Gianluca Matteoli at the IEO, who together have donemost of the experiments, have now provided greater molecular definition to this picture, demonstrating how,in order for all this to occur you need not only actin, but also Eps8.Without Eps8 it is as if the cell has "flaccid legs": they try to take a step but lose their support andbecome incapable of moving effectively.
This is how the researchers saw them, nearly immobilised eventhough they were still able to present antigen, after they had disrupted the gene encoding Eps8 in thegenome and performed sophisticated 2- and 3-D cellular motility assays.Implications and prospective
This discovery, which sheds light on the molecular mechanisms behind the behaviour of these cells andon their role in the immune system, is very important from a variety of points of view.It could contribute to a better understanding of the body's response to infections by bacteria or virusesand could have considerable impact also in the study and treatment of tumours.
In fact, immune mechanisms are among the control systems that the body normally activates to combatmalignant transformation.
However, cancer cells develop diverse strategies to hide from the policingperformed by cells of the immune system. "In this context, it has emerged that some tumours escapeimmune surveillance by inhibiting, through a mechanism that is not yet clear, the very processes by whichdendritic cells migrate" explains Scita.
The Scientist, who is currently involved in organising the International "Actin-based Motility" convention onLake Maggiore this autumn where the most recent progress in the field of biological processes that controlpathologies associated with defects of cellular motility will be addressed, concludes that: «Based on ourresults, it will be interesting to evaluate how tumour development and aggressiveness are affected bydifferent levels of Eps8 function in these cells and, in the future, knowing the molecular determinants thatallow dendritic cells to migrate could provide the background for targeted interventions to stop tumours orblock the diffusion of metastases".
Source: IFOM
The World Cancer Declaration recognises that to make major reductions in premature deaths, innovative education and training opportunities for healthcare workers in all disciplines of cancer control need to improve significantly.
ecancer plays a critical part in improving access to education for medical professionals.
Every day we help doctors, nurses, patients and their advocates to further their knowledge and improve the quality of care. Please make a donation to support our ongoing work.
Thank you for your support.